Return to search

GenFleet Therapeutics rallies $75m Series C

GenFleet Therapeutics, a clinical-stage biotechnology company with a focus on therapies in oncology and immunology, has raised $75 million in Series C financing.

GenFleet Therapeutics, a clinical-stage biotechnology company with a focus on therapies in oncology and immunology, has raised $75 million in Series C financing. Huagai Capital led the round with participation from other backers that included Suxin Venture Capital, Cherami Investment Group, ABC International, DYEE Capital, Qiaojing Eastern Investment, Baidu Venture, and Wenzhou Capital.

Source: Press Release